For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...

The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

A new study finds that an increasing number of surgeries — and the painkillers that follow — could derail recovery for those who once misused opioids.

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other parts of the brain. A new preclinical study has identified a gene therapy ap ...

Please provide your email address to receive an email when new articles are posted on . Opioids prescribing declined from 2016 to 2020 for patients with cancer in Connecticut who did not report ...

Please provide your email address to receive an email when new articles are posted on . Three measures of opioid prescribing for people with cancer declined significantly after cannabis dispensaries ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. It's a question spine surgeon Richard ...

Kids with broken or sprained limbs don't need oral opioids to treat their pain, according to newly published findings from a cross-Canada study by pediatric emergency researchers. The study is ...

Add Yahoo as a preferred source to see more of our stories on Google. For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to ...